Research Article
[Retracted] The Burden of Psoriasis in China and Global Level from 1990 to 2019: A Systematic Analysis from the Global Burden of Disease Study 2019
Table 1
Prevalence of psoriasis in globe and China.
(a) |
| | Characteristics | 1990 | | (95% UI) | Adolescent (95% UI) | 20-55 (95% UI) | 55 plus (95% UI) | ASR per 100,000 (95% UI) |
| | Global | | | | | | | Both | 31585.43 (30534.51-32628.38) | 5352.04 (5043.61-5698.88) | 16912.8 (16157.97-17661.23) | 9320.59 (8911.25-9782.55) | 660.22 (637.42-681.47) | | Female | 16018.77 (15482.37-16544.06) | 2862.14 (2699.38-3047.46) | 8276.86 (7903.11-8649.47) | 4879.78 (4669.68-5114.38) | 657.86 (635.71-679.03) | | Male | 15566.65 (15031.01-16080.61) | 2489.9 (2346.61-2655.24) | 8635.94 (8239.57-9015.96) | 4440.82 (4235.44-4660.91) | 662.7 (639.35-683.78) | | China | | | | | | | Both | 6335.48 (6103.05-6560.48) | 1026.99 (963.64-1096.48) | 3683.09 (3510.17-3856.87) | 1625.39 (1547.5-1713.34) | 577.92 (556.62-597.26) | | Female | 2996.48 (2888.22-3107.76) | 579.37 (543.13-618.2) | 1705.02 (1622.19-1788.5) | 712.1 (677.59-750.3) | 549.27 (529.62-568) | | Male | 3338.99 (3214.42-3460.59) | 447.62 (420.28-479.16) | 1978.08 (1885.07-2067.78) | 913.29 (864.83-963.45) | 601.65 (578.73-622.6) |
|
|
(b) |
| | Characteristics | 2019 | | All ages (95% UI) | Adolescent (95% UI) | 20-55 (95% UI) | 55 plus (95% UI) | ASR per 100,000 (95% UI) |
| | Global | | | | | | | Both | 40805.39 (39421.38-42076.75) | 5010.35 (4720.49-5344.08) | 20928.06 (19983.16-21848.87) | 14866.97 (14224.12-15561.58) | 503.62 (486.92-519.22) | | Female | 20356.5 (19672.49-20990.7) | 2618.98 (2470.07-2789.4) | 10206.11 (9739.65-10644.28) | 7531.41 (7210.12-7872.17) | 497.55 (481.1-513.08) | | Male | 20448.88 (19749.82-21083.37) | 2391.37 (2255.56-2554.03) | 10721.95 (10241.45-11186.42) | 7335.56 (7018.88-7685.5) | 510.67 (493.44-526.4) | | China | | | | | | | Both | 7653.27 (7385.81-7908.31) | 507.42 (477.44-540.66) | 4146.3 (3949.07-4337.9) | 2999.55 (2862.15-3151.37) | 434.82 (420.27-448.33) | | Female | 3478.99 (3361.97-3591.07) | 278.07 (261.29-296.54) | 1858.25 (1773.71-1941.59) | 1342.67 (1281.53-1408.24) | 415.41 (401.69-428.06) | | Male | 4174.28 (4016.31-4319.14) | 229.35 (215.77-244.69) | 2288.05 (2181.72-2393.98) | 1656.88 (1578.42-1745) | 454.78 (438.22-469.42) |
|
|
(c) |
| | Characteristics | Continued 1990-2019 | | All ages change no. (95% CI) | Adolescent change no. (95% CI) | 20-55 change no. (95% CI) | 55 plus change no. (95% CI) | ASR change no. (95% CI) |
| | Global | | | | | | | Both | 0.29 (0.28 to 0.3) | -0.06 (-0.07 to -0.06) | 0.24 (0.23 to 0.25) | 0.6 (0.59 to 0.6) | -0.24 (-0.24 to -0.23) | | Female | 0.27 (0.26 to 0.28) | -0.08 (-0.09 to -0.08) | 0.23 (0.22 to 0.24) | 0.54 (0.53 to 0.55) | -0.24 (-0.25 to -0.24) | | Male | 0.31 (0.3 to 0.32) | -0.04 (-0.05 to -0.03) | 0.24 (0.23 to 0.25) | 0.65 (0.64 to 0.66) | -0.23 (-0.23 to -0.23) | | China | | | | | | | Both | 0.21 (0.19 to 0.22) | -0.51 (-0.51 to -0.5) | 0.13 (0.1 to 0.15) | 0.85 (0.83 to 0.87) | -0.25 (-0.25 to -0.24) | | Female | 0.16 (0.14 to 0.18) | -0.52 (-0.53 to -0.51) | 0.09 (0.07 to 0.11) | 0.89 (0.86 to 0.91) | -0.24 (-0.25 to -0.24) | | Male | 0.25 (0.23 to 0.27) | -0.49 (-0.5 to -0.48) | 0.16 (0.13 to 0.18) | 0.81 (0.79 to 0.84) | -0.24 (-0.25 to -0.24) |
|
|
